Amid PD-1 Uncertainty, Bristol Under Pressure For M&A Activity

Bristol-Myers-Squib_685347493_1200.jpg
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Anticancer